-
Drosophila Edem2 (CG5682) is an ER-resident, GH47 / class I alpha-mannosidase-like
ERAD factor (EDEM family) that promotes disposal of misfolded glycoprotein
clients in the ER, improving proteostasis under proteotoxic burden.
"EDEM proteins (ER degradation-enhancing α-mannosidase-like proteins) are class I α-mannosidase-like factors (GH47-related) implicated in accelerating disposal of misfolded glycoproteins"
-
In Drosophila, overexpression of wild-type dEDEM2 reduces steady-state NHK
protein levels whereas the catalytic mutant E144Q increases NHK, implying that
mannosidase catalytic activity contributes to clearance of at least some
glycoprotein ERAD substrates; some protective effects (e.g. against Abeta42)
persist with catalytic mutants, implying additional non-enzymatic roles.
"overexpression of wild-type dEDEM2 reduced steady-state NHK protein levels, whereas a catalytically inactive mutant (E144Q) increased NHK levels, implying that **mannosidase-catalytic activity contributes to clearance of at least some glycoprotein ERAD substrates**"
-
Conserved mechanistic framing places EDEM2 at the first mannose-trimming step
that initiates glycoprotein ERAD (gpERAD), acting on high-mannose N-glycans of
misfolded glycoproteins (in mammals as an EDEM2-TXNDC11 complex), making this
the most parsimonious model for Drosophila Edem2.
"EDEM2 is an **α1,2-mannose trimming enzyme** acting on **high-mannose N-glycans** of misfolded glycoproteins to promote gpERAD commitment"
-
Mammalian EDEM1/EDEM2 mannosidase activity is folding-state dependent, being much
higher on unfolded/denatured glycoproteins (trimming toward smaller high-mannose
species, M8 to M5), consistent with selective action on misfolded ER clients.
"EDEM2’s mannosidase activity is much higher on **unfolded/denatured glycoproteins**, trimming N-glycans to smaller high-mannose species (reported endpoints include M8→M5 species)"
-
In a Drosophila retinitis-pigmentosa model, Edem2 overexpression selectively
reduced misfolded Rh-1G69D (not wild-type Rh-1), physically associated with
Rh-1G69D, suppressed the xbp1-EGFP ER-stress reporter, and delayed retinal
degeneration, indicating substrate-selective ER quality control upstream of UPR.
"Edem2 overexpression selectively reduced mutant Rh-1G69D levels (but not wild-type Rh-1), physically associated with Rh-1G69D, suppressed an ER-stress reporter (**xbp1-EGFP**), and delayed adult retinal degeneration"
-
Genetic analysis in photoreceptors shows Edem2-dependent ERAD is substrate-selective:
loss of Edem1/Edem2 did not rescue EMC3-dependent loss of Rh1/TRP, indicating some
client degradation is ERAD-independent while other substrates remain Edem-dependent.
"did not rescue EMC3-dependent losses of Rh1/TRP, supporting the conclusion that some client degradation is **ERAD-independent** while other substrates remain **Edem-dependent**"